Nine Major European Pharma Companies Warn of Investment Decline in Joint Open Letter
The chairs of nine of Europe's largest pharmaceutical companies published a joint open letter warning that Europe's share of global pharmaceutical R&D has fallen.
Ipsen
Ipsen and Marengo Therapeutics Announce Second Strategic Partnership
Ipsen and Marengo Therapeutics Inc, a clinical-stage biotech company, announced today the expansion of their ongoing oncology research partnership, to include TriStar, Marengo’s next-generation, precision T cell engager (TCE) technology.
Ipsen and Marengo in Cancer Collaboration
French biopharma Ipsen and US-based Marengo Therapeutics have formed a strategic partnership that aims to advance two of Marengo’s preclinical immuno-oncology candidates.
Ipsen in Talks to Sell Consumer Healthcare to Mayoly Spindler
French pharma Ipsen has entered into exclusive negotiations for the sale of its global consumer healthcare business to compatriot firm Mayoly Spindler. The move, said Ipsen, is a major step forward in its strategy to sharpen its focus on specialty care.
